Literature DB >> 6887532

[A case of severe defibrination syndrome due to snake (Rhabdophis tigrinus) bite].

K Mori, S Hisa, S Suzuki, K Sugai, H Sakai, T Kikuchi, N Hiwatashi, H Shishido, Y Goto, T Takahashi.   

Abstract

Entities:  

Mesh:

Year:  1983        PMID: 6887532

Source DB:  PubMed          Journal:  Rinsho Ketsueki        ISSN: 0485-1439


× No keyword cloud information.
  5 in total

1.  Attempt for a Recombinant Thrombomodulin Alpha Treatment in a Rat Disseminated Intravascular Coagulation Model Using Yamakagashi (Rhabdophis tigrinus) Venom.

Authors:  Akihiko Yamamoto; Takashi Ito; Toru Hifumi
Journal:  Toxins (Basel)       Date:  2022-05-02       Impact factor: 5.075

2.  Clinical characteristics of yamakagashi (Rhabdophis tigrinus) bites: a national survey in Japan, 2000-2013.

Authors:  Toru Hifumi; Atsushi Sakai; Akihiko Yamamoto; Masahiro Murakawa; Manabu Ato; Keigo Shibayama; Akihiko Ginnaga; Hiroshi Kato; Yuichi Koido; Junichi Inoue; Yuko Abe; Kenya Kawakita; Masanobu Hagiike; Yasuhiro Kuroda
Journal:  J Intensive Care       Date:  2014-03-06

3.  Current treatment for venom-induced consumption coagulopathy resulting from snakebite.

Authors:  Kalana Maduwage; Geoffrey K Isbister
Journal:  PLoS Negl Trop Dis       Date:  2014-10-23

4.  Attempt to Develop Rat Disseminated Intravascular Coagulation Model Using Yamakagashi (Rhabdophis tigrinus) Venom Injection.

Authors:  Akihiko Yamamoto; Takashi Ito; Toru Hifumi
Journal:  Toxins (Basel)       Date:  2021-02-18       Impact factor: 4.546

Review 5.  Bioactive Molecules Derived from Snake Venoms with Therapeutic Potential for the Treatment of Thrombo-Cardiovascular Disorders Associated with COVID-19.

Authors:  Fatah Chérifi; Fatima Laraba-Djebari
Journal:  Protein J       Date:  2021-09-09       Impact factor: 2.371

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.